Fig. 1From: Nanomedicine-based adjuvant therapy: a promising solution for lung cancerReprinted with permission [32]. Copyright 2019, Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim  A Scheme illustration of cooperative cancer treatment by combining CA4 nanodrug and MMP9-activated DOX prodrug nanomedicine. B Immunofluorescence images and quantitative analysis of MMP9 in tumor tissues. C Tumor volume and D tumor inhibition rate of 4T1 tumor model.Back to article page